Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

PFIZER INC

SummaryNewsRatingsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Pfizer Inc. : Pfizer Partnership Organizations Significantly Benefit From Pfizer's Global Health Fellows Program

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/22/2013 | 08:10am EDT

Pfizer Celebrates 10th Anniversary of this Signature Social Investment Program

Pfizer Inc. is proud to celebrate the 10th anniversary of its Global Health Fellows Program (GHF) as part of its corporate social investment strategy that focuses on leveraging the full range of the company's resources -- people, medicines, expertise and funding -- to broaden access to medicines and strengthen health care delivery for underserved people around the world.

GHF is Pfizer's signature corporate volunteer program that pairs colleagues from technical and functional areas across Pfizer in three- to six- month fellowships with international development organizations to improve health services for people in greatest need.

"Since the first year of the Pfizer GHF Program, Project HOPE has benefited from the extraordinary expertise of Pfizer employees, working in our field sites in Latin America, Africa, Asia and Central Europe," said Cary Kimble, Associate Vice President, Development, Project HOPE. "These members of the Pfizer family have helped improve Project HOPE's monitoring and evaluation systems and our health education curricula and materials, have helped measure and validate the impact of our work, have helped develop business and marketing plans, and have allowed us to reach more people, more effectively."

The 10th anniversary Fellows class is from technical and business functions from across six Pfizer locations: United Kingdom, Ireland, Australia, Germany, Canada and the United States. Combined, the 2013 class will be sharing 156 years of Pfizer experience with eleven GHF partner organizations to optimize supply chains and scale-up promising health prevention approaches, such as diabetes and cardiovascular disease awareness and screening initiatives and business strategy and development functions in China, India and East Africa.

"The tenth anniversary of this vibrant program vividly demonstrates our commitment to promoting access, quality and efficiency of health services for the world's neediest people," said Caroline Roan, President of the Pfizer Foundation and Vice President of Corporate Social Responsibility. "It also offers clear evidence that by coordinating our efforts and partnering with other stakeholders, the impact of our effort is magnified and we all benefit."

A 2012 study by Boston University's Center for International Health and Development revealed that 100 percent of partners reported Global Health Fellows helped them to accelerate sustainable change in their health service delivery efforts. In addition, partnership organizations reported "extremely significant" and "significant" capacity gains in Human Resources training and development; Leadership and Governance; and Health Management Information Systems.

"Fellows become an integral part of the regional GBCHealth team, working closely with us to deliver on their complex scopes of work," said Elizabeth Sorensen, Vice President, Human Resources, GBCHealth. "Their impact has been described as lifesaving, significant, insightful, and amazing."

Since 2003, 317 colleagues have completed an estimated 325,000 hours of skills-based volunteering, which is valued at approximately $47.6M of pro-bono service to partner organizations throughout the developing world. Through GHF, Pfizer has partnered with more than 40 international development organizations in more than 40 countries over the life of the program.

For additional information on Pfizer's Global Health Fellows Program, please visit www.pfizer.com/GHF.

Pfizer Inc.
Jennifer Kokell, 212.733.2596


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PFIZER INC
09/19PFIZER : Description Statement of Changes in Beneficial Ownership
PU
09/19PFIZER : Presents Scientific Advancements in Cancer Care at the ESMO Congress 20..
BU
09/17PFIZER : Invites Public to View and Listen to Webcast of October 29 Conference C..
BU
09/17PFIZER : Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococc..
PU
09/16PFIZER : Description Statement of Changes in Beneficial Ownership
PU
09/13Biopharmaceutical Company Imara Inc. Files Confidentially for IPO
DJ
09/12PFIZER : Description Initial Statement of Beneficial Ownership
PU
09/12PFIZER : SpringWorks Therapeutics IPO Prices at High End of Range
DJ
09/12PFIZER : Catalia Health and Pfizer collaborate to better understand patient jour..
PU
09/12GLAXOSMITHKLINE : ViiV Healthcare - Stigma and mental health challenges remain b..
AQ
More news
Chart PFIZER INC
Duration : Period :
Pfizer Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Albert Bourla Director, Chief Executive & Operating Officer
Ian C. Read Executive Chairman
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC201 939
JOHNSON & JOHNSON1.05%343 382
ROCHE HOLDING LTD.14.65%243 639
MERCK AND COMPANY9.89%214 995
PFIZER-16.36%201 939
NOVARTIS15.63%198 194